No sign of 'obesity paradox' in obese patients with stroke

Researchers found no evidence of an "obesity paradox" (some studies have suggested overweight or obese patients have lower mortality rates than underweight or normal weight patients) in patients with stroke.

Obesity often is associated with increased health related complications and death. But some studies have suggested an obesity paradox that may cause some to question striving for a .

The authors sought to determine whether the obesity paradox in stroke was real or an artificial finding because of selection bias in studies. To overcome selection bias, authors only studied deaths caused by the index stroke using a Danish register of stroke and a registry of deaths. The study included 71,617 Danes for whom information was available on factors that included (BMI), age, stroke type and stroke severity.

Of the 71,617 , 7,878 (11 percent) died within the first month and, of these, stroke was reported as the cause of death of 5,512 patients (70 percent). Of the patients for whom BMI information was available, 9.7 percent were underweight, 39 percent were normal weight, 34.5 percent were overweight and 16.8 percent were obese. BMI was inversely related to average age of stroke onset (high BMI associated with younger age of onset).

"This study was unable to confirm the existence of an obesity paradox in stroke. … Obesity was not associated with a lower risk for death after a stroke. … The risk of with stroke for death did not differ from that of normal-weight patients with nor was there evidence of a survival advantage associated with being overweight." Christian Dehlendorff, M.S., Ph.D., of the Danish Cancer Society Research Center, Copenhagen, Denmark, and colleagues said in their JAMA Neurology paper.

More information: JAMA Neurol. Published online June 2, 2014. DOI: 10.1001/.jamaneurol.2014.1017

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Why upper motor neurons degenerate in ALS

12 hours ago

For the first time, scientists have revealed a mechanism underlying the cellular degeneration of upper motor neurons, a small group of neurons in the brain recently shown to play a major role in ALS pathology.

Study finds novel compound switches off epilepsy development

13 hours ago

Researchers at the LSU Health New Orleans Neuroscience Center of Excellence have found that a novel compound they discovered helps curtail the onset and progression of temporal lobe epilepsy. The finding, which may contribute ...

A challenge to expedite Genervon's new ASL drug

Jan 27, 2015

(Medical Xpress)—The Ice Bucket Challenge to raise awareness for Amyotrophic lateral sclerosis (ALS) went viral on social media last summer. Over 1.2 million videos were posted on Facebook alone. The difficulty ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.